51. The Pharmacological Properties and Therapeutic Use of Bitter Melon (Momordica charantia L.)
- Author
-
Shiming Li, Zhiliang Li, Zhang Mingju, Shuzhen Wang, Jin Weibin, Guliang Yang, and Xia Aolei
- Subjects
0301 basic medicine ,Pharmacology ,chemistry.chemical_classification ,Antioxidant ,Traditional medicine ,Momordica ,biology ,medicine.medical_treatment ,Pharmacology toxicology ,Active components ,Bitter melon ,biology.organism_classification ,Biochemistry ,Amino acid ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,Triterpenoid ,chemistry ,In vivo ,030220 oncology & carcinogenesis ,Drug Discovery ,Genetics ,medicine - Abstract
Momordica charantia L., a typical vegetable with multiple medicinal properties, is widely culti-vated around the world. Anti-diabetic, anti-obesity, anti-cancer, anti-microbial, hypotensive, antioxidant, anti-hyperlipidemic, anti-inflammatory, immunomodulatory, anthelmintic, and protective properties have been well clarified both in vitro and in vivo, which might be due to various phytochemicals, such as carbohydrates, protein, fatty acids, amino acids, phenolic acids, minerals, essential oils, alkaloids, vitamins, flavonoids, and triterpenoids. This review summarizes the active components and medicinal properties of different parts of M. charantia, especially the anti-diabetic and anti-cancer properties, aiming to highlight the medicinal usage of M. charantia and provide valuable references for the development of M. charantia as multifunctional food and medicine.
- Published
- 2020